Oak Street Health, Inc.
OSH · NYSE
3/31/2023 | 12/31/2022 | 9/30/2022 | 6/30/2022 | |
|---|---|---|---|---|
| Revenue | $752 | $578 | $546 | $524 |
| % Growth | 30.2% | 5.9% | 4.2% | – |
| Cost of Goods Sold | $0 | $577 | $541 | $491 |
| Gross Profit | $752 | $1 | $5 | $33 |
| % Margin | 100% | 0.2% | 0.9% | 6.3% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $90 | $80 | $82 | $95 |
| SG&A Expenses | $132 | $123 | $126 | $138 |
| Sales & Mktg Exp. | $42 | $44 | $44 | $43 |
| Other Operating Expenses | $663 | $10 | $9 | $8 |
| Operating Expenses | $795 | $133 | $135 | $146 |
| Operating Income | -$43 | -$132 | -$130 | -$113 |
| % Margin | -5.8% | -22.9% | -23.9% | -21.5% |
| Other Income/Exp. Net | -$2 | -$1 | -$0 | -$36 |
| Pre-Tax Income | -$46 | -$134 | -$130 | -$148 |
| Tax Expense | $3 | $1 | $1 | $36 |
| Net Income | -$48 | -$135 | -$131 | -$185 |
| % Margin | -6.4% | -23.4% | -24% | -35.3% |
| EPS | -0.2 | -0.61 | -0.56 | -0.82 |
| % Growth | 67.2% | -8.9% | 31.7% | – |
| EPS Diluted | -0.2 | -0.61 | -0.56 | -0.82 |
| Weighted Avg Shares Out | 238 | 223 | 232 | 226 |
| Weighted Avg Shares Out Dil | 238 | 223 | 232 | 226 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | -$1 | $1 | $0 | $1 |
| Depreciation & Amortization | $129 | $9 | $9 | -$27 |
| EBITDA | $86 | -$123 | -$122 | -$139 |
| % Margin | 11.4% | -21.3% | -22.4% | -26.6% |